公开(公告)号：US20070026051A1

公开(公告)日：2007-02-01

申请号：US10556900

申请日：2004-05-26

申请人： Palaniswamy Sunderraj ,  Adrian Shephard ,  Huw Jones

发明人： Palaniswamy Sunderraj ,  Adrian Shephard ,  Huw Jones

IPC分类号： A61K31/4439 ,  A61K9/70

CPC分类号： A61K31/4439

摘要： There is disclosed the use of a consumable film comprising triprolidine for enabling an individual to wake refreshed after sleep and the method of treating such an individual with triprolidine. Use of a consumable film comprising triprolidine as active ingredient in the manufacture of a composition for the treatment of sleep disorders is also described. A method of treating sleep of a person suffering from a sleep disorder, which method comprises administration of a consumable film comprising an effective dose of triprolidine as active ingredient to such a person is also described. The triprolidine is administered shortly before a person wishes to fall asleep, preferably orally and most commonly in the form of a tablet containing up to 20 mg, e.g. 0.1 mg, 1.25 mg or 2.5 mg, of the active ingredient. The triprolidine is also effective in enabling an individual to sleep more easily.

摘要翻译： 公开了使用包含triprolidine的消耗性膜以使得个体在睡眠后醒来醒来以及使用三氯哌啶来治疗这种个体的方法。 还描述了在制备用于治疗睡眠障碍的组合物中使用包含三洛定作为活性成分的消耗性膜。 还描述了治疗患有睡眠障碍的人的睡眠的方法，该方法包括将包含有效剂量的三洛定作为活性成分的消耗性薄膜给予这种人。 三吡咯烷在人想要入睡之前不久就被施用，优选口服，最通常是含有至多20mg的片剂形式，例如， 0.1mg，1.25mg或2.5mg的活性成分。 三吡咯也有助于使个体更容易睡觉。

公开(公告)号：US20070015800A1

公开(公告)日：2007-01-18

申请号：US11303019

申请日：2005-12-16

申请人： Palaniswamy Sunderraj

发明人： Palaniswamy Sunderraj

IPC分类号： A61K31/4439

CPC分类号： A61K9/0095 ,  A61K9/2018 ,  A61K9/205 ,  A61K9/2054 ,  A61K31/4439

摘要： There is disclosed the use of triprolidine for enabling an individual to wake refreshed after sleep and the method of treating such an individual with triprolidine. The triprolidine is administered shortly before a person wishes to fall asleep, preferably orally and most commonly in the form of a tablet containing less than 5 mg, eg 0.1 mg, 1.25 mg or 2.5 mg, of the active ingredient. The triprolidine is also effective in enabling an individual to sleep more easily.

摘要翻译： 公开了使用triprolidine以使个体在睡眠后醒来醒来以及用三氯吡啶治疗这种个体的方法。 三吡咯烷在人想要入睡之前不久就被施用，优选口服，最通常是含有少于5mg（例如0.1mg，1.25mg或2.5mg）活性成分的片剂形式。 三吡咯也有助于使个体更容易睡觉。